<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Brain</journal-id>
<journal-title-group>
<journal-title>Molecular Brain</journal-title>
</journal-title-group>
<issn pub-type="epub">1756-6606</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31747920</article-id>
<article-id pub-id-type="pmc">6864969</article-id>
<article-id pub-id-type="publisher-id">519</article-id>
<article-id pub-id-type="doi">10.1186/s13041-019-0519-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Micro Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Autism-like behaviors in male mice with a <italic>Pcdh19</italic> deletion</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lim</surname>
<given-names>Jisoo</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ryu</surname>
<given-names>Jiin</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Shinwon</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Noh</surname>
<given-names>Hyun Jong</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7360-429X</contrib-id>
<name>
<surname>Kim</surname>
<given-names>Chul Hoon</given-names>
</name>
<address>
<email>kimhoon@yuhs.ac</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution>Department of Pharmacology, BK21 PLUS Project for Medical Science, </institution><institution>Brain Research Institute, Yonsei University College of Medicine, </institution></institution-wrap>Seoul, 03722 Korea </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution>Severance Biomedical Science Institute, Yonsei University College of Medicine, </institution></institution-wrap>Seoul, 03722 Korea </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>20</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<elocation-id>95</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Mutations in protocadherin 19 (<italic>PCDH19</italic>), which is on the X-chromosome, cause the brain disease Epilepsy in Females with Mental Retardation (EFMR). EFMR is also often associated with autism-like symptoms. In mice and humans, epilepsy occurs only in heterozygous females who have a mixture of <italic>PCDH19</italic> wild-type (WT) and mutant cells caused by random X-inactivation; it does not occur in hemizygous <italic>PCDH19</italic> mutant males. This unique inheritance pattern strongly suggests the underlying disease mechanism operates via interference between WT and mutant cells rather than being a result of complete loss of PCDH19 functions. Although it remains unclear whether the other symptoms of EFMR also conform to this unique genotype-phenotype relationship, <italic>PCDH19</italic> mutant males were recently reported to demonstrate autism-like symptoms. We, therefore, used a <italic>Pcdh19</italic> knockout (KO) mouse model to ask whether a complete lack of PCDH19 causes autism-like behaviors. Consistent with the autism observed in EFMR females, we found <italic>Pcdh19</italic> heterozygous KO female mice (with mosaic expression of PCDH19) show defects in sociability in the 3-chamber test. Surprisingly, hemizygous <italic>Pcdh19</italic> KO male mice (without any PCDH19 expression) exhibit impaired sociability in the 3-chamber test and reduced social interactions in the reciprocal social interaction test. We also observed that, compared to WT mice, mutant mice display more repetitive behaviors, including self-grooming and rearing. These findings indicate that hemizygous <italic>Pcdh19</italic> KO male mice show autism-like phenotypes.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>
<institution>National Research Foundation of Korea</institution>
</funding-source>
<award-id>NRF-2019R1A2C3002354</award-id>
<principal-award-recipient>
<name>
<surname>Kim</surname>
<given-names>Chul Hoon</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p id="Par10">Epilepsy in Females with Mental Retardation (EFMR) is reportedly caused by mutations (i.e., missense, nonsense, and deletion, etc.) in the X-linked gene protocadherin 19 (<italic>PCDH19</italic>) [<xref ref-type="bibr" rid="CR1">1</xref>]. EFMR patients have early-onset seizures frequently associated with varying degrees of intellectual disability (ID) and autism-like symptoms [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. As the name of the disease implies, it is highly sex-limited. Epileptic symptoms appear only in females heterozygous for <italic>PCDH19</italic> mutations, whereas males hemizygous for <italic>PCDH19</italic> mutations are unaffected carriers [<xref ref-type="bibr" rid="CR5">5</xref>]. Because <italic>PCDH19</italic> is X-linked, it is subject to random X-inactivation, producing mosaic expression in heterozygous mutant females [<xref ref-type="bibr" rid="CR1">1</xref>]. The identification of male patients affected by postzygotic somatic <italic>PCDH19</italic> mutations supports the idea that the disease mechanism is related to mosaic expression of PCDH19 [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. This idea is further supported by the case of an epileptic patient with Klinefelter Syndrome (47, XXY) heterozygous for a <italic>PCDH19</italic> mutation [<xref ref-type="bibr" rid="CR8">8</xref>]. This unique genotype-phenotype relationship suggests the symptoms of EFMR emerge from the abnormal interaction of two different populations of brain cells, some with and some without PCDH19 expression. This cellular mechanism is referred to as “cellular interference” [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p>
<p id="Par11">Recently, Pederick et al. [<xref ref-type="bibr" rid="CR9">9</xref>] demonstrated a dramatic and abnormal segregation of PCDH19(+) and PCDH19(−) cells in the developing brains of <italic>Pcdh19</italic> heterozygous KO female mice that was well-correlated with seizure-like activities as recorded by electrocorticogram. This result provided the first experimental evidence of cellular interference as a key pathogenic mechanism in EFMR. It is unclear, however, whether autism spectrum disorder (ASD) in EFMR also conforms to both this unusual inheritance pattern and cellular interference mechanism. It is notable that recent human studies identified some males with ASD who have mutations in <italic>PCDH19</italic> [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>], suggesting <italic>PCDH19</italic> mutations may also play a role in producing the symptoms of males with ASD via mechanisms other than cellular interference. In this study, we investigate this possibility using a <italic>Pcdh19</italic> KO mouse model.</p>
<p id="Par12">Consistent with previous studies [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], heterozygous <italic>Pcdh19</italic> KO female mice show an abnormal “tiger-striped” pattern of segregation between PCDH19(+) and PCDH19(−) cells in the brain (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a). In contrast to heterozygous <italic>Pcdh19</italic> KO female mice, we did not observe a similar segregation in hemizygous <italic>Pcdh19</italic> KO male mice, despite both having a <italic>tdTomato</italic> (<italic>tdT</italic>) reporter gene on the X-chromosome where the <italic>Pcdh19</italic> gene was deleted (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a). This finding suggests any phenotypes in hemizygous <italic>Pcdh19</italic> KO male mice are independent of the abnormal sorting mechanism observed in heterozygous <italic>Pcdh19</italic> KO female mice.
<fig id="Fig1"><label>Fig. 1</label><caption><p><italic>Pcdh19</italic> hemizygous KO male mice exhibit autism-like behaviors. <bold>a</bold> Representative images of <italic>tdT</italic>-expressing cells (PCDH19-negative cells) in coronal sections of HET-<italic>tdT</italic> female and KO-<italic>tdT</italic> male brains at P56 (left). Scale bar, 200 μm. Schematic diagrams of the X and Y chromosomes of heterozygous KO female and hemizygous KO male mice, showing <italic>tdT</italic> and <italic>Pcdh19</italic>-null alleles (in which the PCDH19 coding sequence is replaced with a <italic>LacZ</italic> cassette) are located on the same X-chromosome; X<sup><italic>LacZ-tdT</italic></sup> (right). <bold>b</bold> Group-averaged heat map images for the movement of WT (X/Y) and <italic>Pcdh19</italic> hemizygous KO (X<sup><italic>LacZ</italic></sup>/Y) male mice during the 3-chamber sociability test (S1 vs O). <bold>c</bold> Quantification of the results shown as sniffing time, based on the time spent sniffing S1 vs O in the sociability test and S1 vs S2 in the social novelty test (*<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, paired Student’s <italic>t</italic> test). <bold>d</bold> The time of social interaction of <italic>Pcdh19</italic> KO male mice during the reciprocal social interaction test. <bold>e-f</bold> Repetitive behavior tests: the number of rearing incident (<bold>e</bold>) and the time spent self-grooming (<bold>f</bold>) in <italic>Pcdh19</italic> KO male mice (*<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, unpaired Student’s <italic>t</italic> test). <italic>n</italic> = 10–12 male mice per genotype. All data are presented as means ± SEM</p></caption><graphic id="MO1" xlink:href="13041_2019_519_Fig1_HTML"></graphic></fig></p>
<p id="Par13">First, we asked whether heterozygous <italic>Pcdh19</italic> KO female mice show autism-like behaviors in our experimental setting (see Additional file <xref ref-type="media" rid="MOESM1">1</xref> for the detailed methods). We found that heterozygous <italic>Pcdh19</italic> KO female mice (X<sup><italic>LacZ</italic></sup>/X) do not show any preference toward exploring a novel mouse (S1) versus a non-social novel object (O) in the 3-chamber test (the sociability test). This suggests heterozygous <italic>Pcdh19</italic> KO female mice recapitulate the autism-like symptoms of female EFMR patients. In the social novelty test, in which we measured preference toward a familiar mouse (S1) and a novel mouse (S2), we found the heterozygous <italic>Pcdh19</italic> KO mice (X<sup><italic>LacZ</italic></sup>/X) spend more time exploring the novel mouse (S2) (see Additional file <xref ref-type="media" rid="MOESM2">2</xref>).</p>
<p id="Par14">We next examined the male mice to determine whether they also show any social impairment. In the 3-chamber sociability test, we found male <italic>Pcdh19</italic> KO (X<sup><italic>LacZ</italic></sup>/Y) mice spend significantly more time sniffing a non-social novel object (O) rather than a novel mouse (S1), suggesting abnormal sociality. Both hemizygous males and controls, however, show similar preference towards a novel mouse (S2) in the social novelty test (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b–c). We then measured reciprocal social interactions to confirm the social abnormalities of male <italic>Pcdh19</italic> KO (X<sup><italic>LacZ</italic></sup>/Y) mice. We found they spend significantly less time interacting with a stranger mouse than WT (X/Y) mice do (Fig. <xref ref-type="fig" rid="Fig1">1</xref>d). To determine whether male <italic>Pcdh19</italic> KO (X<sup><italic>LacZ</italic></sup>/Y) mice show increased repetitive behavior—another autism-like phenotype—we monitored their rearing and stereotyped grooming behaviors. We found <italic>Pcdh19</italic> X<sup><italic>LacZ</italic></sup>/Y male mice spend more time rearing and self-grooming (Fig. <xref ref-type="fig" rid="Fig1">1</xref>e–f) than WT (X/Y) male mice. Thus, their abnormal social interaction results and increased repetitive behaviors suggest hemizygous <italic>Pcdh19</italic> KO (X<sup><italic>LacZ</italic></sup>/Y) mice show autism-like behaviors.</p>
<p id="Par15">We do not yet know how the complete loss of <italic>Pcdh19</italic> causes autism-like behaviors in male mice, but considering the fact that the abnormal segregation pattern occurs only in the brain of female heterozygous <italic>Pcdh19</italic> KO mice [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], but not in male KO mice, our present findings suggest the mechanism will be distinct from the cellular interference mechanism that underlies the epileptic symptoms of EFMR. It is possible a loss of PCDH19-mediated cell-to-cell adhesion may contribute to autism-like behaviors in hemizygous <italic>Pcdh19</italic> male KO mice. PCDH19 regulates intracellular binding proteins like NONO and the GABA<sub>A</sub> receptor alpha subunits [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Hence, it is also possible the absence of PCDH19 disrupts the function of unidentified autism-related binding proteins. Our social interaction results were inconsistent with a previous study in which heterozygous KO female and hemizygous KO male mice showed no abnormalities in the social interaction tests [<xref ref-type="bibr" rid="CR12">12</xref>]. In fact, we are still unclear why the mice showed this inconsistency, but we found that the background of the mouse, the targeted exons, and the size of the behavioral apparatus used for the experiment were all different.</p>
<p id="Par16">This is the first report showing, in genetically modified mice, that autism-like behaviors induced by <italic>Pcdh19</italic> mutations are not subject to the same genotype-phenotype relationship observed in epileptic symptoms of EFMR. From this finding, we postulate that both mosaic expression of <italic>PCDH19</italic> and <italic>PCDH19</italic> insufficiency contribute to the pathogenesis of EFMR. Considering the fact that male patients affected by mosaic <italic>PCDH19</italic> mutations also show autism [<xref ref-type="bibr" rid="CR6">6</xref>], the induction of autism in a male patient may not require complete loss of PCDH19 in every cell. In the future, the generation of male mice with mosaic <italic>Pcdh19</italic> deletions will help address the question of whether both mosaic loss and complete loss of <italic>PCDH19</italic> result in autism-like behaviors.</p>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec1">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13041_2019_519_MOESM1_ESM.docx"><caption><p><bold>Additional file 1.</bold> Materials and Methods.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13041_2019_519_MOESM2_ESM.docx"><caption><p><bold>Additional file 2: Figure S1.</bold>
<italic>Pcdh19</italic> heterozygous KO female mice display autistic-like behaviors in the 3-chamber sociability test.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ASD</term>
<def>
<p id="Par2">Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>EFMR</term>
<def>
<p id="Par3">Epilepsy in females with mental retardation</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p id="Par4">Intellectual disability</p>
</def>
</def-item>
<def-item>
<term>KO</term>
<def>
<p id="Par5">Knockout</p>
</def>
</def-item>
<def-item>
<term>PCDH19</term>
<def>
<p id="Par6">Protocadherin 19</p>
</def>
</def-item>
<def-item>
<term>SEM</term>
<def>
<p id="Par7">Standard error of the mean</p>
</def>
</def-item>
<def-item>
<term>tdT</term>
<def>
<p id="Par8">tdTomato</p>
</def>
</def-item>
<def-item>
<term>WT</term>
<def>
<p id="Par9">Wild-type</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13041-019-0519-3.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>CHK conceptualized and designed the research. JL, JR, SK, HJN conducted the behavioral experiments. CHK, JL analyzed, interpreted the data. CHK, JL prepared the manuscript. All authors read and approved the final manuscript.</p>
<sec id="FPar1">
<title>Authors’ information</title>
<p id="Par17">Not applicable.</p>
</sec>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2019R1A2C3002354) and a faculty research grant of Yonsei University College of Medicine for 2013 (6–2013-0072).</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>All data and materials are available upon requests.</p>
</notes>
<notes>
<title>Ethics approval</title>
<p id="Par18">All animal experiments were performed in compliance with guidelines approved by the Institutional Animal Care and Use Committee (IACUC) of Yonsei University Health System (reference number: 2018–0285).</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par19">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par20">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dibbens</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Tarpey</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Hynes</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bayly</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment</article-title>
<source/>Nat Genet
          <year>2008</year>
<volume>40</volume>
<issue>6</issue>
<fpage>776</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1038/ng.149</pub-id>
<pub-id pub-id-type="pmid">18469813</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Specchio</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Marini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Terracciano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Trivisano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sicca</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations</article-title>
<source/>Epilepsia
          <year>2011</year>
<volume>52</volume>
<issue>7</issue>
<fpage>1251</fpage>
<lpage>1257</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03063.x</pub-id>
<pub-id pub-id-type="pmid">21480887</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Dibbens</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Bayly</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Friend</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hodgson</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epilepsy and mental retardation limited to females: an under-recognized disorder</article-title>
<source/>Brain
          <year>2008</year>
<volume>131</volume>
<issue>Pt 4</issue>
<fpage>918</fpage>
<lpage>927</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awm338</pub-id>
<pub-id pub-id-type="pmid">18234694</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hynes</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tarpey</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dibbens</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Bayly</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families</article-title>
<source/>J Med Genet
          <year>2010</year>
<volume>47</volume>
<issue>3</issue>
<fpage>211</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2009.068817</pub-id>
<pub-id pub-id-type="pmid">19752159</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryan</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Chance</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Spinner</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Smietana</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing</article-title>
<source/>Nat Genet
          <year>1997</year>
<volume>17</volume>
<issue>1</issue>
<fpage>92</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1038/ng0997-92</pub-id>
<pub-id pub-id-type="pmid">9288105</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Depienne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bouteiller</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Keren</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cheuret</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poirier</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Trouillard</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females</article-title>
<source/>PLoS Genet
          <year>2009</year>
<volume>5</volume>
<issue>2</issue>
<fpage>e1000381</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000381</pub-id>
<pub-id pub-id-type="pmid">19214208</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Lange</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Rump</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Neuteboom</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Augustijn</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Hodges</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kistemaker</surname>
<given-names>AI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Male patients affected by mosaic PCDH19 mutations: five new cases</article-title>
<source/>Neurogenetics
          <year>2017</year>
<volume>18</volume>
<issue>3</issue>
<fpage>147</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-017-0517-5</pub-id>
<pub-id pub-id-type="pmid">28669061</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romasko</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>DeChene</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Balciuniene</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Akgumus</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Helbig</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tarpinian</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PCDH19-related epilepsy in a male with Klinefelter syndrome: additional evidence supporting PCDH19 cellular interference disease mechanism</article-title>
<source/>Epilepsy Res
          <year>2018</year>
<volume>145</volume>
<fpage>89</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2018.06.008</pub-id>
<pub-id pub-id-type="pmid">29933145</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pederick</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Piltz</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mincheva-Tasheva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mandelstam</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abnormal Cell Sorting Underlies the Unique X-Linked Inheritance of PCDH19 Epilepsy</article-title>
<source/>Neuron
          <year>2018</year>
<volume>97</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>66.e5</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2017.12.005</pub-id>
<pub-id pub-id-type="pmid">29301106</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Lafreniere</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Henrion</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2011</year>
<volume>16</volume>
<issue>8</issue>
<fpage>867</fpage>
<lpage>880</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2010.54</pub-id>
<pub-id pub-id-type="pmid">20479760</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Harssel</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Weckhuysen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>van Kempen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hardies</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Verbeek</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>de Kovel</surname>
<given-names>CG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders</article-title>
<source/>Neurogenetics
          <year>2013</year>
<volume>14</volume>
<issue>1</issue>
<fpage>23</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-013-0353-1</pub-id>
<pub-id pub-id-type="pmid">23334464</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shioi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of X-linked Protocadherin-19 differentially affects the behavior of heterozygous female and hemizygous male mice</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<issue>1</issue>
<fpage>5801</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-06374-x</pub-id>
<pub-id pub-id-type="pmid">28724954</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pederick</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Homan</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Jaehne</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Piltz</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Baune</surname>
<given-names>BT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pcdh19 loss-of-function increases neuronal migration in vitro but is dispensable for brain development in mice</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>26765</fpage>
<pub-id pub-id-type="doi">10.1038/srep26765</pub-id>
<pub-id pub-id-type="pmid">27240640</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cwetsch</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Gerosa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Serratto</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Folci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>IF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The female epilepsy protein PCDH19 is a new GABAAR-binding partner that regulates GABAergic transmission as well as migration and morphological maturation of hippocampal neurons</article-title>
<source/>Hum Mol Genet
          <year>2018</year>
<volume>27</volume>
<issue>6</issue>
<fpage>1027</fpage>
<lpage>1038</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddy019</pub-id>
<pub-id pub-id-type="pmid">29360992</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pham</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Homan</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kolc</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>McAninch</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERalpha)</article-title>
<source/>Hum Mol Genet
          <year>2017</year>
<volume>26</volume>
<issue>11</issue>
<fpage>2042</fpage>
<lpage>2052</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddx094</pub-id>
<pub-id pub-id-type="pmid">28334947</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>